Compounds > colchicine
Page last updated: 2024-08-17

colchicine and ER-Negative PR-Negative HER2-Negative Breast Cancer

colchicine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's5 (100.00)2.80

Authors

AuthorsStudies
Al Moustafa, AE; Alali, F; Cyprian, FS; El Sayed, K; Elkhalifa, D; Khalil, A; Qusa, M; Siddique, AB1
Chen, H; Deng, S; Hartman, KL; Krutilina, RI; Li, W; Lukka, PB; Ma, D; Mahmud, F; Meibohm, B; Miller, DD; Parke, DN; Seagroves, TN; Wang, R1
Chen, C; Chen, K; Chiang, C; Liu, Z; Wu, Y; Yang, H; Zhang, T; Zheng, D; Zhou, Y; Zhu, L1
Chambers, TC; Huczyński, A; Jousheghany, F; Klejborowska, G; Majcher-Uchańska, U; Monzavi-Karbassi, B; Moorjani, A; Piña-Oviedo, S; Urbaniak, A; Yuan, Y1
Ishii, T; Itou, J; Sato, F; Tanaka, S; Toi, M1

Other Studies

5 other study(ies) available for colchicine and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
    European journal of medicinal chemistry, 2020, Feb-01, Volume: 187

    Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; Chalcone; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Models, Molecular; Molecular Structure; Nitrogen; Structure-Activity Relationship; Triple Negative Breast Neoplasms; Tumor Cells, Cultured

2020
Colchicine-Binding Site Agent CH-2-77 as a Potent Tubulin Inhibitor Suppressing Triple-Negative Breast Cancer.
    Molecular cancer therapeutics, 2022, 07-05, Volume: 21, Issue:7

    Topics: Apoptosis; Binding Sites; Cell Line, Tumor; Cell Proliferation; Colchicine; Humans; Paclitaxel; Triple Negative Breast Neoplasms; Tubulin; Tubulin Modulators

2022
Laxiflorin B covalently binds the tubulin colchicine-binding site to inhibit triple negative breast cancer proliferation and induce apoptosis.
    Chemico-biological interactions, 2023, Sep-25, Volume: 383

    Topics: Animals; Apoptosis; Binding Sites; Cell Proliferation; Colchicine; Diterpenes, Kaurane; Humans; Mice; Triple Negative Breast Neoplasms; Tubulin

2023
Carbamate derivatives of colchicine show potent activity towards primary acute lymphoblastic leukemia and primary breast cancer cells-in vitro and ex vivo study.
    Journal of biochemical and molecular toxicology, 2020, Volume: 34, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carbamates; Carcinoma, Ductal, Breast; Cell Proliferation; Cell Survival; Colchicine; Colchicum; Drug Screening Assays, Antitumor; Female; Humans; Inhibitory Concentration 50; MCF-7 Cells; Middle Aged; Plant Extracts; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Estrogen; Triple Negative Breast Neoplasms

2020
Eribulin mesylate-induced c-Fos upregulation enhances cell survival in breast cancer cell lines.
    Biochemical and biophysical research communications, 2020, 05-21, Volume: 526, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzophenones; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colchicine; Female; Furans; Gene Expression Regulation, Neoplastic; Humans; Isoxazoles; Ketones; Mice, Inbred BALB C; Mice, Nude; Microtubules; Paclitaxel; Proto-Oncogene Proteins c-fos; RNA, Messenger; Triple Negative Breast Neoplasms; Up-Regulation

2020